Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 471-478

  Reiser, Markus ^a,c   Marousis, Constantine G ^a   Nelson, David R ^a   Lauer, Georg ^a,c   González Peralta, Regino P ^a,b   Davis, Gary L ^a   Lau, Johnson Y N ^a  

^a Section of Hepatobiliary Diseases   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

CD30; hepatitis C virus; immune mechanisms; interleukin 10; interleukin 4; T helper 2

Indexed keywords

CD30 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0031041141     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80409-6     Document Type: Article

References (38)

1. Gonzalez-Peralta RP, Lau JYN. Pathogenic mechanisms for hepatocellular damage in chronic hepatitis C virus infection. Semin Gastroenterol. 6:1995;28-34.
2. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmag D, Weiner AJ, Choo QL, Shuster JR, Juo G, Bonino F, Houghton M, Abrignani S. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580-587.
3. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295.
4. Kita H, Moriyama T, Kaneko T, Hiroishi K, Harase I, Miura H, Nakamura I, Inamori H, Kodama T, Ohnishi S, Yazaki Y, Imawari M. A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro. J Med Virol. 45:1995;386-391.
5. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR. Possible mechanisms involving T-lymphocyte response to non-structural protein in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
6. Koziel MJ, Dudley A, Afdhal N, Choo QL, Houghton M, Ralston R, Walker B. Hepatitis C virus (HCV) - specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 67:1993;7522-7532.
7. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 149:1992;3339-3344.
8. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 18:1993;1039-1044.
9. Cerny A, McHutchinson JG, Pasquinelli C, Brown ME, Brothers MA, Grabsheid B, Fowler P, Houghton M, Chisari FV. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest. 95:1995;521-530.
10. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, Grakou A, Rice CM, Kurokohchi K, Berzofsky JA, Hoofnagle JH, Feinstone SM, Akaatsuka T. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol. 69:1994;2462-2470.
11. Nelson DR, Marousis CG, Davis GL, Lau JYN. Defining the role of intrahepatic HCV-specific cytotoxic T-lymphocytes in chronic hepatitis C (abstract). Hepatology. 22:1995;287A.
12. Lau JYN. Hepatitis C virus: from epidemiology and molecular virology to immunobiology. Hepatology. 20:1994;760-762.
13. Onji M, Kikuchi T, Kumon I, Masumoto T, Nadano S, Kajino K, Horiike N, Ohta Y. Intrahepatic lymhocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C. Hepatogastroenterology. 39:1992;340-343.
14. González-Peralta RP, Fang JWS, Davis GL, Gish RG, Wu PC, Mizokami M, Lau JYN. Immunopathobiology of chronic hepatitis C virus infection (abstract). Hepatology. 20:(suppl 2):1994;232A.
15. Garside P, Mowat AM. Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defense? Immunol Today. 16:1995;220-223.
16. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol. 138:1987;3688-3694.
17. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7:1989;145-173.
18. Finkelman FD, Pearce EJ, Urban JJ, Sher A. Regulation and biological function of helminth-induced cytokine responses. Immunol Today. 12:1991;A62-A66.
19. Fishman MA, Perelson AS. Th1/Th2 cross regulation. J Theor Biol. 70:1994;25-56.
20. Pernis A, Gupta S, Kenneth J, Gollob EG, Coffman RL, Schindler C, Rothman P. Lack of interferon-gamma receptor-beta chain and the prevention of interferon-gamma signaling in Th1 cells. Science. 269:1995;245-247.
21. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC III, Shearer GM. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev. 127:1992;182-204.
22. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med. 171:1990;115-127.
23. Clerici M, Shearer GM. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol Today. 14:1993;107-111.
24. Del PG, De CM, Almerigogna F, Daniel CK, D'Elios MM, Zancuoghi G, Vinante F, Pizzolo G, Romagnani S. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J. 9:1995;81-86.
25. Lau JYN, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan S, DiNello R, Polito AJ, Scornik JC. Hepatitis C virus infection in renal transplant recipients. Hepatology. 18:1993;1027-1031.
26. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
27. Urdea MS, Horn T, Fultz TJ, Anderson M, Running JA, Hamren S, et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucl Acid Symp Ser. 23:1993;197-200.
28. Lau JYN, Simmonds P, Urdea MS. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet. 346:1995;425-426.
29. Collins ML, Zayati C, Detmer JJ, Daly B, Kolberg JA, Cha TA, Irvine BD, Tucker J, Urdea MS. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem. 226:1995;120-129.
30. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1203.
31. van Doorn J, Kleter B, Stuyver L, Maertens G, Brouwer H, Schalm S, Heijtink R, Quint W. Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles. J Hepatol. 21:1995;122-129.
32. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers TM, Date T, Esteban JI, Fay O, Han J, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie N, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Shimotochno K, Stuyer L, Trepo C, Weiner A, Yap PL, Urdea MS. A proposed system for the nomenclature of hepatitis C viral genotypes [correspondence]. Hepatology. 19:1994;1321-1324.
33. Acute and chronic hepatitis revisited. Lancet. ii:1997;914-919.
34. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymtomatic chronic active hapatitis. Hepatology. 1:1981;431-435.
35. Cacciarelli TV, Martinez OM, Villaneuva JC, Gish RG, Krams SM. Immunoregulatory cytokines in hepatitis C virus (HCV) infection pre and post treatment with interferon-α (abstract). Gastroenterology. 108:1995;A1042.
36. Napoli J, Bishop GA, McGuiness P, Painer DM, McGaughan GW. Increased intrahepatic TH1 cytokine mRNA levels correlate with tissue damage in chronic hepatitis C (abstract). Hepatology. 22:1995;222A.
37. Missale G, Rochford R, Hobbs M, Giuberti T, Ferrari C, Fiaccadori F, Chisari FV. Cytokine messanger RNA within the liver in chronic hepatitis B virus and hepatitis C virus infection (abstract). J Hepatol. 21:((suppl 1)):1994;S54.
38. Dumoulin FL, Dúx F, Leifeld L, Herbst H, Sauerbrunch T, Spengler U. Intrahepatic expression of interleukin-10 mRNA in chronic liver disease (abstract). Gastroenterology. 108:1995;A1059.